Rimegepant 75mg; orally disintegrating tabs (ODT). Concomitant strong CYP3A4 inhibitors: Avoid use with Nurtec ODT. Concomitant moderate CYP3A4 inhibitors: Avoid another dose of Nurtec ODT within ...

Its not known whether Nurtec ODT (rimegepant) is safe to take while pregnant or breastfeeding. Certain factors, including the risks of not treating your condition during pregnancy, may determine ...

The Department of Justice (DoJ) claims that Biohaven – before being acquired by Pfizer – paid "improper remuneration" to some Nurtec ODT (rimegepant) prescribers in the form of speaker fees ...

Sales of Nurtec ODT (rimegepant) – approved as an oral therapy for migraine prevention and acute treatment – reached $194 million in sales in the fourth quarter of 2022. It competes with other ...

Paxlovid revenues beat the Zacks Consensus Estimate of $589 million and our model estimate of $546 million. The newly acquired product Nurtec ODT/Vydura contributed $392 million in the quarter ...

Nurtec ODT (rimegepant) is a prescription drug that treats and helps prevent migraine episodes. It works by blocking a certain protein in the brain and nervous system that can cause migraine.